ZA85529B - Topical drug release system - Google Patents

Topical drug release system

Info

Publication number
ZA85529B
ZA85529B ZA85529A ZA85529A ZA85529B ZA 85529 B ZA85529 B ZA 85529B ZA 85529 A ZA85529 A ZA 85529A ZA 85529 A ZA85529 A ZA 85529A ZA 85529 B ZA85529 B ZA 85529B
Authority
ZA
South Africa
Prior art keywords
drug
phase
liquid
phases
drug release
Prior art date
Application number
ZA85529A
Other languages
English (en)
Inventor
Adrian Francis Davis
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA85529B publication Critical patent/ZA85529B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Confectionery (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA85529A 1984-01-25 1985-01-23 Topical drug release system ZA85529B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848401965A GB8401965D0 (en) 1984-01-25 1984-01-25 Composition

Publications (1)

Publication Number Publication Date
ZA85529B true ZA85529B (en) 1985-11-27

Family

ID=10555518

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85529A ZA85529B (en) 1984-01-25 1985-01-23 Topical drug release system

Country Status (11)

Country Link
US (1) US4767751A (de)
EP (1) EP0151953B1 (de)
JP (1) JPS60174715A (de)
AT (1) ATE71519T1 (de)
AU (1) AU576344B2 (de)
CA (1) CA1249520A (de)
DE (1) DE3585162D1 (de)
DK (1) DK163799C (de)
GB (1) GB8401965D0 (de)
IE (1) IE57733B1 (de)
ZA (1) ZA85529B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
EP0252459A1 (de) * 1986-07-07 1988-01-13 Schering Corporation Kompartimentiertes transdermales Abgabesystem
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
IN168400B (de) * 1987-01-30 1991-03-23 Colgate Palmolive Co
US5180578A (en) * 1987-01-30 1993-01-19 Colgate-Palmolive Company Antibacterial antiplaque anticalculus oral composition
US4894220A (en) * 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5178851A (en) * 1987-01-30 1993-01-12 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US4935225A (en) * 1987-09-11 1990-06-19 Curtis John P Appetite suppresant dentifrice
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
US5681964A (en) * 1990-10-23 1997-10-28 University Of Kentucky Research Foundation Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
GB9025711D0 (en) * 1990-11-27 1991-01-09 Beecham Group Plc Topical composition
AU668679B2 (en) * 1991-02-18 1996-05-16 Transdermal Technologies Pty Limited Composition for use in transdermal administration
GB9118711D0 (en) * 1991-08-31 1991-10-16 Smithkline Beecham Plc Novel device
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
US5290541A (en) * 1992-06-18 1994-03-01 The Procter & Gamble Company Methods for making oral compositions
FI944321A7 (fi) * 1992-11-05 1994-11-16 Becton Dickinson Co Käyttäjäaktivoitu iontoforeettinen laite ja menetelmä sen käyttämiseks i
US5290542A (en) * 1993-04-08 1994-03-01 The Procter & Gamble Company Oral compositions for treating plaque and gingivitis
US5474761A (en) * 1993-04-08 1995-12-12 The Procter & Gamble Company Oral compositions for treating plaque and gingivitis
US5807569A (en) * 1993-05-27 1998-09-15 Smithkline Beecham P.L.C. Topical composition
WO1995004520A1 (en) * 1993-08-06 1995-02-16 Embro William J Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
US5900249A (en) * 1998-02-09 1999-05-04 Smith; David J. Multicomponent pain relief topical medication
US6765019B1 (en) * 1999-05-06 2004-07-20 University Of Kentucky Research Foundation Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
KR100990810B1 (ko) * 2001-12-21 2010-10-29 알콘, 인코퍼레이티드 안과용 약물 및 이과용 약물을 위한 담체로서 합성 무기 나노입자의 용도
KR20040073503A (ko) * 2001-12-21 2004-08-19 알콘, 인코퍼레이티드 안과용 및 이과용 약제학적 조성물의 점도 및 기타물리학적 성질을 개질시키기 위한 무기 나노입자의 용도
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20090017047A1 (en) * 2004-06-11 2009-01-15 Egon Tech Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders
EP2457560A1 (de) 2006-06-14 2012-05-30 Dr Reddy's Laboratories Limited Topische Zusammensetzungen
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
US8114159B2 (en) 2006-11-20 2012-02-14 Depuy Spine, Inc. Anterior spinal vessel protector
PE20130245A1 (es) * 2009-12-16 2013-03-08 Shasun Pharmaceuticals Ltd Composicion de hidrogel de dexibuprofeno transdermico
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
PT2704703T (pt) 2011-05-03 2019-10-25 Aponia Laboratories Inc Composições transdermais de ibuprofeno e seus métodos de utilização.
KR102643849B1 (ko) 2015-06-18 2024-03-07 밸리언트 파마슈티컬즈 노오쓰 아메리카 엘엘씨 건선을 치료하기 위한 코르티코스테로이드 및 레티노이드를 포함하는 국소 조성물
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
CA3117842A1 (en) 2018-10-26 2020-04-30 Viramal Limited Mucoadhesive gel composition
ES2948955T3 (es) 2018-11-30 2023-09-22 Viramal Ltd Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante
JP2024540701A (ja) 2021-11-08 2024-11-01 リー・ウェイヨン 患者に薬物を送達するための経皮薬物送達システム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582207A (en) * 1977-05-16 1981-01-07 Sanol Arznei Schwarz Gmbh Stable isosorbide dinitrate solutions preparation thereof and use thereof
US4140656A (en) * 1977-10-07 1979-02-20 Armour-Dial, Inc. Anhydrous clear gel facial cleanser
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition

Also Published As

Publication number Publication date
EP0151953A2 (de) 1985-08-21
AU3800885A (en) 1985-08-01
AU576344B2 (en) 1988-08-25
JPS60174715A (ja) 1985-09-09
CA1249520A (en) 1989-01-31
ATE71519T1 (de) 1992-02-15
IE850146L (en) 1985-07-25
EP0151953A3 (en) 1987-01-21
JPH0430923B2 (de) 1992-05-25
EP0151953B1 (de) 1992-01-15
DK30585A (da) 1985-07-26
DK163799C (da) 1992-08-31
DK30585D0 (da) 1985-01-23
DE3585162D1 (de) 1992-02-27
IE57733B1 (en) 1993-04-07
GB8401965D0 (en) 1984-02-29
DK163799B (da) 1992-04-06
US4767751A (en) 1988-08-30

Similar Documents

Publication Publication Date Title
EP0151953A3 (en) Topical drug release system
EP0289342A3 (de) Verfahren zur Behandlung der mit dem Rauchstop verbundenen Entwöhnungssymptome sowie Mittel zur Verwendung in diesem Verfahren
ATE95057T1 (de) Oertliches arzneimittel mit verzoegerter wirkstoffabgabe.
MY101570A (en) Novel pharmaceutical compositions for topical application with systemic action
IL82192A (en) System for administration of drugs to the skin and process for the preparation thereof
SG52784G (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa,and method for administration thereof
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
IE831925L (en) Perfluorocarbon emulsions
EP0224981A3 (de) Transdermales Einbringungssystem für Nitroglycerin
ZA879248B (en) Topical drug release system
Eymontt et al. The effects on synovial permeability and synovial fluid leukocyte counts in symptomatic osteoarthritis after intraarticular corticosteroid administration
SE8703971D0 (sv) Losliga och/eller sonderdelbara tabletter och sett att framstella dessa
FI843609A7 (fi) Nestemäiset, ionisia aineosia sisältävät farmaseuttiset valmisteet, jotka pidentävät lääkeaineen vapautumista.
ES8701490A1 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
JPS5572108A (en) Preparation for transcutaneous administration, composed mainly of nitroglycerine
Mizuno Differences of gastric cancers between the greater and the lesser curvature Part III. On the differences of the ribose nucleic acid content of the cancer cells between the greater and the lesser curvatures
Cheng et al. Intrauterine injection of 20 per cent saline for inducing abortion
JPS5250447A (en) Lock structure of tightening nut